Browse
related articles
Globalpharma wins India deal
- United Arab Emirates: Sunday, August 13 - 2006 at 09:52
Globalpharma has signed a contract with Ethypharm India to secure the marketing and distribution rights for five new products in different therapeutic segments. Ethypharm will be responsible for the development and supply of the five products, whereas Globalpharma will be responsible for the manufacturing, marketing and distribution of the products in the Middle East and Gulf markets.
Also consider reading:
Today's top stories
Week's top stories
Browse
related articles
- » Moody's: UAE banks with largest exposures to Dubai World remain on review
- » Abu Dhabi to 'pick and choose' Dubai support
- » Samsung halts Dubai bridge work amidst Dubai debt crisis
- » Dubai World announcement serves as wake-up call to world markets
- » Emirate of Abu Dhabi 'AA/A-1+' sovereign ratings affirmed; outlook stable
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
Jonathan Sheikh-Miller, Deputy Editor
